戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lymphocytic choriomeningitis virus and human parainfluenza virus type 3.
2 ion, which was 40-fold lower than that of WT parainfluenza virus type 3.
3                                        Human parainfluenza virus type 3, a mildly cytopathic virus th
4 s of a live-attenuated vaccine candidate for parainfluenza virus type 3, an enveloped RNA virus that
5                                    For human parainfluenza virus type 3 and many other paramyxoviruse
6 tial innate antiviral response against human parainfluenza virus type 3 and respiratory syncytial vir
7 yncytial virus, human metapneumovirus, human parainfluenza virus type 3, and measles virus, and highl
8 fever (SF) and Kansas (Ka) strains of bovine parainfluenza virus type 3 (BPIV3) are restricted in the
9                  The Kansas strain of bovine parainfluenza virus type 3 (BPIV3) is 100- to 1,000-fold
10                                       Bovine parainfluenza virus type 3 (bPIV3) is being evaluated as
11 raminidase (HN) glycoprotein genes of bovine parainfluenza virus type 3 (BPIV3) to its restricted rep
12 to evaluate the antibody responses to bovine parainfluenza virus type 3 (bPIV3) vaccination in young
13  doses of an intranasal vaccine using bovine parainfluenza virus type 3 (bPIV3).
14                                 Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia i
15 uses, including the childhood pathogen human parainfluenza virus type 3, enter host cells by fusion o
16 explores the binding and entry into cells of parainfluenza virus type 3, focusing on how the receptor
17                        The envelope of human parainfluenza virus type 3 (HPF3) contains two viral gly
18                        The envelope of human parainfluenza virus type 3 (HPF3) contains two viral gly
19                    Entry and fusion of human parainfluenza virus type 3 (HPF3) require the interactio
20                    Entry and fusion of human parainfluenza virus type 3 (HPF3) requires interaction o
21 erence have not been characterized for human parainfluenza virus type 3 (HPF3), and the possible role
22  inhibit the neuraminidase activity of human parainfluenza virus type 3 (HPF3).
23 ur previous observation on the role of human parainfluenza virus type 3 (HPIV 3) C protein in the tra
24          The RNA polymerase complex of human parainfluenza virus type 3 (HPIV 3), a member of the fam
25 paramyxovirus simian virus 5 (SV5) and human parainfluenza virus type 3 (HPIV-3) fusion (F) proteins
26             A full-length clone of the human parainfluenza virus type 3 (HPIV-3) genome (called pHPIV
27                                        Human parainfluenza virus type 3 (hPIV-3) is a clinically sign
28                                        Human parainfluenza virus type 3 (HPIV-3) is an airborne patho
29                                        Human parainfluenza virus type 3 (HPIV-3) is an airborne patho
30 es, respiratory syncytial virus (RSV), human parainfluenza virus type 3 (HPIV-3), and measles virus (
31 on factor, with the cis-acting RNAs of human parainfluenza virus type 3 (HPIV3) and packaging of thes
32 valent live attenuated vaccine against human parainfluenza virus type 3 (HPIV3) and respiratory syncy
33  respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are major pediatric r
34  respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are major viral agent
35 SV), human metapneumovirus (hMPV), and human parainfluenza virus type 3 (hPIV3) are responsible for t
36  Respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are the first and sec
37  Respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are two major causes
38                The genomic promoter of human parainfluenza virus type 3 (HPIV3) contains multiple cis
39                                    The human parainfluenza virus type 3 (HPIV3) fusion (F) and hemagg
40                                        Human parainfluenza virus type 3 (HPIV3) genome RNA is transcr
41 genes, of a gene cassette encoding the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neurami
42 t also the receptor interaction of the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neurami
43 plementation to follow the dynamics of human parainfluenza virus type 3 (HPIV3) HN/F pairs in living
44 , participates in the transcription of human parainfluenza virus type 3 (HPIV3) in vitro.
45                    We demonstrate that human parainfluenza virus type 3 (HPIV3) induces incomplete au
46                                        Human parainfluenza virus type 3 (HPIV3) infection causes seve
47                                        Human parainfluenza virus type 3 (HPIV3) is one of the major c
48        It was previously reported that human parainfluenza virus type 3 (HPIV3) multiplication was in
49 onnected to the stalk region of either human parainfluenza virus type 3 (HPIV3) or Nipah virus recept
50                   We have analyzed the human parainfluenza virus type 3 (HPIV3) P protein and deletio
51 binant virus rHPIV3-N(B), a version of human parainfluenza virus type 3 (HPIV3) that is attenuated du
52  against Ebola virus (EV), recombinant human parainfluenza virus type 3 (HPIV3) was modified to expre
53 rt here that for three paramyxoviruses-human parainfluenza virus type 3 (HPIV3), a major cause of low
54                                        Human parainfluenza virus type 3 (HPIV3), a paramyxovirus, is
55 monkeys 100- to 1,000-fold compared to human parainfluenza virus type 3 (HPIV3), and the Ka strain al
56 common pediatric respiratory pathogen, human parainfluenza virus type 3 (HPIV3), as a vaccine vector
57  encephalomyocarditis virus (EMCV) and human parainfluenza virus type 3 (HPIV3), induced down-regulat
58 ing the childhood respiratory pathogen human parainfluenza virus type 3 (HPIV3), possess an envelope
59                                    For human parainfluenza virus type 3 (HPIV3), the effects of speci
60                                    For human parainfluenza virus type 3 (HPIV3), the receptor binding
61 aminidase (HN) surface glycoprotein of human parainfluenza virus type 3 (HPIV3).
62  intranasal paediatric vaccine against human parainfluenza virus type 3 (HPIV3).
63 s), Newcastle disease virus (NDV), and human parainfluenza virus type 3 (HPIV3).
64 s virus of the Arenaviridae family and human parainfluenza virus type 3 of the Paramyxoviridae family
65 paramyxoviruses, Sendai virus (SN) and human parainfluenza virus type 3 (PI3), was constructed and co
66 tory syncytial virus (RSV) and one strain of parainfluenza virus type 3 (PIV-3) was determined.
67  respiratory syncytial virus (RSV) and human parainfluenza virus type-3 (PIV-3) mediate virus entry a
68 nd attenuation (att) phenotypes of the human parainfluenza virus type 3 (PIV3) cp45 live attenuated v
69 In this study, a chimeric bovine/human (b/h) parainfluenza virus type 3 (PIV3) expressing the human P
70                 The recent recovery of human parainfluenza virus type 3 (PIV3) from cDNA, together wi
71                                              Parainfluenza virus type 3 (PIV3) infection led to laryn
72                                              Parainfluenza virus type 3 (PIV3) infections are a major
73                                              Parainfluenza virus type 3 (PIV3) is major pathogen of c
74                                          Two parainfluenza virus type 3 (PIV3) vaccine candidates-cp4
75                    During a phase 2 trial of parainfluenza virus type 3 (PIV3) vaccine, sequential se
76                            Recombinant human parainfluenza virus type 3 (PIV3) was used as a vector t
77 r the ability to inhibit the growth of human parainfluenza virus type 3 (PIV3), a nonsegmented negati
78         We have previously demonstrated that parainfluenza virus type 3 (PIV3), a significant respira
79           Respiratory syncytial virus (RSV), parainfluenza virus type 3 (PIV3), and rhinovirus (RV) 1
80                     A live attenuated bovine parainfluenza virus type 3 (PIV3), harboring the fusion
81      A live attenuated chimeric bovine/human parainfluenza virus type 3 (rB/HPIV3) was developed prev
82                     Recombinant bovine/human parainfluenza virus type 3 (rB/HPIV3), a recombinant bov
83           We constructed a human recombinant parainfluenza virus type 3 (rPIV3) that expresses enhanc
84 minidase abolished infection of HAE by human parainfluenza virus type 3, this treatment did not signi
85  vaccine for respiratory syncytial virus and parainfluenza virus type 3, two major causes of severe r
86  protective efficacy of an aerosolized human parainfluenza virus type 3-vectored vaccine that express
87  viruses, including the human pathogen human parainfluenza virus type 3, yet these compounds by thems

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。